View on market: Volatility Prevails, Market is searching for better value
Early on Thursday, the markets in South Korea and Japan were rising, following Wall Street’s overnight gains. At 6:30 a.m., the KOSPI index was trading 10.68 points, or 0.41%, higher at 2,620.26, while the Nikkei 225 was trading 284.52 points, or 0.79%, higher. Investors are awaiting Chinese inflation statistics and will be watching the conclusion of today’s policy meeting of the Reserve Bank of India. Stocks rose as a result of a surge in tech megacaps, and the S&P 500 is getting closer to reaching the 5,000 mark. Prior to a record $42 billion offering of 10-year Treasury bonds, U.S. bonds dipped, according to Bloomberg. As of Wednesday, the Nasdaq Composite and S&P 500 index both increased by 0.45% and 0.82%, respectively. By 0.41%, the Dow Jones Industrial Average increased.
Economic Calendar:
- USD : Initial Jobless Claims on 08th February, 2024
- USD : CPI (MoM) (Jan) on 13th February, 2024
- INR : Interest Rate Decision on 08th February, 2024
- INR : FX Reserves, USD on 09th February, 2024
Brokerage Radar:
MS ON BHARTI AIRTEL: EW, TP Rs 1015; Steady performance; Key highlights:
- a) Beat in India mobile business revenues and EBITDA led by improving subscriber mix;
- b) flattish capex qoq coming lower than our estimate;
- c) robust cash flow generation.
GS ON ASHOK LEYLAND: Buy, TP Rs 230; 3Q beat as a combination of pricing discipline, favorable RM prices & ongoing optimization in cost Gross margin of 27.8% was 150bps higher than BBG cons; EBITDA margin of 12.%, highest 3Q margin in co’s history (+320bps yoy)
CLSA ON REC: Buy, TP Rs 510; 3Q net profit of Rs33bn up 14% YoY driven by healthy growth in net interest income; Loan growth of 21% YoY strong; Expected negative credit cost in 3Q, but recoveries in one of resolved projects lower
36bp QoQ decline in GNPA is healthy
International Markets:
U.S & Europe:
Particulars | 07th February | Chg. | Chg.(%) |
Nasdaq | 15759.77 | 150.78 | 0.97 |
Dow | 38677.36 | 156.00 | 0.40 |
FTSE | 7628.75 | -52.26 | -0.69 |
CAC | 7611.26 | -27.71 | -0.36 |
DAX | 16921.96 | -111.28 | -0.66 |
Dow Fut.* | 38701.94 | 25.58 | 0.07 |
Asian markets:
Particulars | 08th February | Chg. | Chg.(%) |
GIFT Nifty | 22112.50 | 108.00 | 0.49 |
Nikkei | 36738.42 | 618.50 | 1.68 |
Straits Times | 3145.16 | -10.99 | -0.35 |
Hang Seng | 15926.11 | -155.78 | -0.97 |
Shanghai | 2854.63 | 24.93 | 0.88 |
ADR Watch:
Particulars | 07th February | Chg. | Chg.(%) |
Dr. Reddy | 73.40 | 0.20 | 0.27 |
HDFC Bank | 55.65 | -0.40 | -0.71 |
ICICI Bank | 24.57 | -0.09 | -0.36 |
Infosys | 20.43 | -0.18 | -9.00 |
Wipro | 5.89 | -0.05 | -0.84 |
Commodities & Currency:
Particulars | Current Price | Chg.(%) |
USD/INR | 82.98 | -0.09 |
Brent | 79.54 | 0.42 |
Gold | 2051.65 | 0.00 |
Silver | 22.31 | -0.23 |
FIIs & DIIs:
Particulars | 07th February | 06th February |
FIIs | -1691.02 | 92.52 |
DIIs | 327.73 | 1096.26 |
News Update:
Rate-sensitive stocks: The RBI will announce the decision of its Monetary Policy Committee meeting on Thursday. Banking and finance, auto, housing and real estate stocks will be in focus.
Welspun Enterprise: The company emerged as the lowest bidder for the development of a 2,000 million-litre per-day water treatment plant from the Brihanmumbai Municipal Corp.
Bharat Petroleum Corp: The company’s joint venture, Petronet LNG, executed a long-term LNG sale and purchase agreement with Qatar Energy for the purchase of approximately 7.5 MMTPA of liquified natural gas on a long-term basis.
Zomato: The company intimated the liquidation of two step-down subsidiaries in Vietnam and the Czech Republic.
ONGC: The company formed a joint venture pact with NTPC Green for renewable energy, Bloomberg reported. The joint venture will focus on offshore wind projects.
Indraprastha Gas: The company signed a Memorandum of Understanding with two technology partners during India Energy Week 2024 to establish CBG plants across Delhi, Haryana, Rajasthan, and Uttar Pradesh.
Ashoka Buildcon: The company received a Letter of Award worth Rs 520 crore from the National Highways Authority of India for a project in Bihar.
Piramal Pharma: The U.S. FDA conducted a pre-approval inspection of the company’s U.S.-based facility from Jan. 29 to Feb. 6 and found three observations.
Action Construction Equipment: The company will purchase land worth Rs 82 crore for further capacity and business expansion.
SJVN: The company received a Letter of Intent from Gujarat Urja Vikas Nigam for a 200 MW solar power project.
Bajaj Alliance: The company reported a total new business premium of Rs 951 crore in January and a gross direct premium of Rs 1,975 crore.
Mangalore Chemicals & Fertilizers Ltd: The company’s board has approved merger with the Paradeep Phosphate Ltd.
Source: Moneycontrol, Bloomberg Quint, Investing
Disclosure in pursuance of Section 19 of SEBI (RA) Regulation 2014
Elite Wealth Limited does/does not do business with companies covered in its research reports. Investors should be aware that the Elite Wealth Limited may/may not have a conflict of interest that could affect the objectivity of this report. Investors should consider this report as only information in making their investment decision and must exercise their own judgment before making any investment decision.
For analyst certification and other important disclosures, see the Disclosure Appendix, or go to www.elitewealth.in. Analysts employed by Elite Wealth Limited are registered/qualified as research analysts with SEBI in India.( SEBI Registration No.: INH100002300)
Disclosure Appendix
Analyst Certification (For Reports)
Kiran Tahlani, Elite Wealth Limited, kirantahlani@elitestock.com
The analyst(s) certify that all of the views expressed in this report accurately reflect my/our personal views about the subject company or companies and its or their securities. I/We also certify that no part of my compensation was, is or will be, directly or indirectly, related to the specific recommendations or views expressed in this report. Unless otherwise stated, the individuals listed on the cover page of this report are analysts in Elite Wealth Limited.
As to each individual report referenced herein, the primary research analyst(s) named within the report individually certify, with respect to each security or issuer that the analyst covered in the report, that:
(1) all of the views expressed in the report accurately reflect his or her personal views about any and all of the subject securities or issuers; and
(2) no part of any of the research analyst’s compensation was, is, or will be directly or indirectly related to the specific recommendations or views expressed in the report.
For individual analyst certifications, please refer to the disclosure section at the end of the attached individual notes.
Research Excerpts
This note may include excerpts from previously published research. For access to the full reports, including analyst certification and important disclosures, investment thesis, valuation methodology, and risks to rating and price targets, please visit www.elitewealth.in.
Company-Specific Disclosures
Important disclosures, including price charts, are available and all Elite Wealth Limited covered companies by visiting https://www.elitewealth.in, or e-mailing research@elitestock.com with your request. Elite Wealth Limited may screen companies based on Strategy, Technical, and Quantitative Research. For important disclosures for these companies, please e-mail research@elitestock.com.
Options related research:
If the information contained herein regards options related research, such information is available only to persons who have received the proper option risk disclosure documents. For a copy of the risk disclosure documents, please contact your Broker’s Representative or visit the OCC’s website at https://www.elitewealth.in
Other Disclosures
All research reports made available to clients are simultaneously available on our client websites. Not all research content is redistributed, e-mailed or made available to third-party aggregators. For all research reports available on a particular stock, please contact your respective broker’s sales person.
Ownership and material conflicts of interest Disclosure
Elite Wealth Limited policy prohibits its analysts, professionals reporting to analysts from owning securities of any company in the analyst’s area of coverage. Analyst compensation: Analysts are salary based permanent employees of Elite Wealth Limited. Analyst as officer or director: Elite Wealth Limited policy prohibits its analysts, persons reporting to analysts from serving as an officer, director, board member or employee of any company in the analyst’s area of coverage.
Country Specific Disclosures
India – For private circulation only, not for sale.
Legal Entities Disclosures
Mr. Ravinder Parkash Seth is the Managing Director of Elite Wealth Ltd (EWL, henceforth), having its registered office at Casa Picasso, Golf Course Extension, Near Rajesh Pilot Chowk, Radha Swami, Sector-61, Gurgaon-122001 Haryana, is a SEBI registered Research Analyst and is regulated by Securities and Exchange Board of India. Telephone: 011-43035555, Facsimile: 011-22795783 and Website: www.elitewealth.in
EWL discloses all material information about itself including its business activity, disciplinary history, the terms and conditions on which it offers research report, details of associates and such other information as is necessary to take an investment decision, including the following:
- Reports
- a) EWL or his associate or his relative has no financial interest in the subject company and the nature of such financial interest;
(b) EWL or its associates or relatives, have no actual/beneficial ownership of one per cent. or more in the securities of the subject company, at the end of the month immediately preceding the date of publication of the research report or date of the public appearance;
(c) EWL or its associate or his relative, has no other material conflict of interest at the time of publication of the research report or at the time of public appearance;
- Compensation
(a) EWL or its associates have not received any compensation from the subject company in the past twelve months;
(b) EWL or its associates have not managed or co-managed public offering of securities for the subject company in the past twelve months;
(c) EWL or its associates have not received any compensation for investment banking or merchant banking or brokerage services from the subject company in the past twelve months;
(d) EWL or its associates have not received any compensation for products or services other than investment banking or merchant banking or brokerage services from the subject company in the past twelve months;
(e) EWL or its associates have not received any compensation or other benefits from the subject company or third party in connection with the research report.
3 In respect of Public Appearances
(a) EWL or its associates have not received any compensation from the subject company in the past twelve months;
(b) The subject company is not now or never a client during twelve months preceding the date of distribution of the research report and the types of services provided by EWL
Provided that research analyst or research entity shall not be required to make a disclosure as per sub-clauses (c), (d) and (e) of clause (ii) or sub-clauses (a) and (b) of clause (iii) to the extent such disclosure would reveal material non-public information regarding specific potential future investment banking or merchant banking or brokerage services transactions of the subject company.
(4) EWL or its proprietor has never served as an officer, director or employee of the subject company;
(5) EWL has never been engaged in market making activity for the subject company;
(6) EWL shall provide all other disclosures in research report and public appearance as specified by the Board under any other regulations.